The nation of Zimbabwe has declined a substantial US health deal valued at $367m (£272m) over five years because of Washington's demand for sensitive biological samples.
The decision was revealed following a government memo dated December was leaked, which showed President Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesman has since explained that the United States was requesting genetic material for scientific study and commercial purposes but was unwilling to share the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate process of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had donated over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for continued dialogue to reach a deal agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.
Broader Context
This rejection follows a comparable situation in neighbouring Kenya, where a high court halted a similar health funding agreement following legal challenges were filed about the security of Kenyans' medical information.
After resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was seeking government-to-government agreements to enhance openness and accountability.
As per reports, Sixteen African countries have so far signed similar agreements, representing over $18.3bn of fresh investment.
Specifics of the Rejected Deal
The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy via US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, with no equivalent assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that shared data," he stated.
"Put simply, our country would provide the basic resources for scientific discovery without any assurance that the end products would be accessible to our population if a new health crisis arise."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were upending systems previously established via the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to manage future global health emergencies.
"This mechanism is designed to guarantee that when a nation provides its information, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."
These objections over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome continued dialogue with our American counterparts on how future co-operation could be arranged in a way that honours the independence and interests of both nations."
Health Experts Response
Medical experts expressed it understood the government's concerns, but urged that talks should continue since much of the country's Aids initiatives were funded by international support.
"In cases where technical issues arise, including those relating to data governance or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," it added.
The halted deal emphasises the continuing tensions between receiving vital international aid and protecting local interests in an ever more interconnected world.